The Research Pathology Shared Service at the Arizona Cancer Center (ACC) was established in 1994 to provide routine histology and pathology services for researchers. A developmental Molecular and Cellular Imaging Shared Service began in 1996 under the directorship of Claire Payne, Ph.D., research professor of microbiology and immunology. These two services were combined to make the Molecular and Cellular Pathology Shared Service in 1997 with Thomas Grogan, M.D., professor of pathology, and Dr. Payne as co-directors. The expanded service includes a wide variety of state-of-the-art pathology services and a large inventory of instruments to facilitate automated tissue processing, immunohistochemistry (IHC) and in situ hybridization (ISH). It also includes instrumentation for sophisticated microscopy via confocal, transmission and scanning electron microscopy and image quantitation. The combined laboratories of Drs. Grogan and Payne will provide a wide array of staining and imaging capabilities. The service now includes: 1) animal and human histology services; 2) tissue collection and preservation in a tumor band, including micro-dissection capability; 3) tissue staining including both immunohistochemistry and in situ hybridization with an associated antibody bank; 4) imaging via fluorescence, confocal, transmission and scanning microscopy including digital image acquisition and quantitation via morphometry, apoptosis quantitation and oxidative stress assays; and 5) a consultation service regarding experimental design, assay, imaging methods and interpretation. The merge of the core histology lab with the molecular, cellular imaging lab has resulted in a 50% increase in lab usage, suggesting the newly merged facility has improved efficacy as well as scientific gain.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023074-23
Application #
6323278
Study Section
Project Start
2000-07-01
Project End
2001-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
23
Fiscal Year
2000
Total Cost
$150,220
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Kobes, Joseph E; Georgiev, George I; Louis, Anthony V et al. (2018) A Comparison of Iron Oxide Particles and Silica Particles for Tracking Organ Recellularization. Mol Imaging 17:1536012118787322
Kelly, K R; Espitia, C M; Zhao, W et al. (2018) Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy. Leukemia 32:230-233
Downs, Charles A; Johnson, Nicholle M; Tsaprailis, George et al. (2018) RAGE-induced changes in the proteome of alveolar epithelial cells. J Proteomics 177:11-20
Sun, Virginia; Wendel, Christopher S; Demark-Wahnefried, Wendy et al. (2018) Diet and Behavior Modifications by Long-term Rectal Cancer Survivors to Manage Bowel Dysfunction-Associated Symptoms. Nutr Cancer :1-11
Mushtaq, Adeela; Kapoor, Vikas; Latif, Azka et al. (2018) Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review. Crit Rev Oncol Hematol 125:1-11
Rak, Michael A; Buehler, Jason; Zeltzer, Sebastian et al. (2018) Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency. J Virol 92:
Rojo de la Vega, Montserrat; Zhang, Donna D; Wondrak, Georg T (2018) Topical Bixin Confers NRF2-Dependent Protection Against Photodamage and Hair Graying in Mouse Skin. Front Pharmacol 9:287
Bea, Jennifer W; de Heer, Hendrik Dirk; Valdez, Luis et al. (2018) Physical Activity among Navajo Cancer Survivors: A Qualitative Study. Am Indian Alsk Native Ment Health Res 25:54-73
Siyahian, Aida; Malik, Saad Ullah; Mushtaq, Adeela et al. (2018) Prophylaxis for Hepatitis B Virus Reactivation after Allogeneic Stem Cell Transplantation in the Era of Drug Resistance and Newer Antivirals: A Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant 24:1483-1489
Stanton, Annette L; Wiley, Joshua F; Krull, Jennifer L et al. (2018) Cancer-related coping processes as predictors of depressive symptoms, trajectories, and episodes. J Consult Clin Psychol 86:820-830

Showing the most recent 10 out of 1336 publications